Retraction notice to “Kaempferol suppresses proliferation but increases apoptosis and autophagy by up-regulating microRNA-340 in human lung cancer cells” [Biomed. Pharmacother. 108 (2018) 809–816, (S0753332218334395), (10.1016/j.biopha.2018.09.087)];Kaempferol suppresses proliferation but increases apoptosis and autophagy by up-regulating microRNA-340 in human lung cancer cells

Biomedicine and Pharmacotherapy

Volumn 108, Issue , 2018, Pages 809-816

  Han, Xue ^a   Liu, Chun Fang ^a   Gao, Na ^a   Zhao, Jing ^a   Xu, Jian ^a  

^a DALIAN MUNICIPAL CENTRAL HOSPITAL   (China)

Author keywords

Apoptosis; Autophagy; Lung cancer; miR 340; Proliferation; PTEN PI3K AKT

Indexed keywords

AGENTS AFFECTING METABOLISM; AUTOPHAGY RELATED PROTEIN 7; BECLIN 1; BETA ACTIN; CASPASE 3; CASPASE 9; CYCLIN D1; KAEMPFEROL; MESSENGER RNA; MICRORNA; MICRORNA 340; MICRORNA 340 INHIBITOR; MICROTUBULE ASSOCIATED PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; SEQUESTOSOME 1; TUMOR MARKER; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; KAEMPFEROL DERIVATIVE; MIRN340 MICRORNA, HUMAN;

A-549 CELL LINE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL PROLIFERATION; CELL STIMULATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MRNA EXPRESSION LEVEL; PI3K/AKT SIGNALING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN EXPRESSION LEVEL; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING; DRUG EFFECT; GENETICS; LUNG TUMOR; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

A549 CELLS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAEMPFEROLS; LUNG NEOPLASMS; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 85053806630     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2022.112853     Document Type: Erratum

References (41)

1. Karczmarek-Borowska, B., Tobiasz, M., Bukała, A., [Acceptance of the disease in patients with lung cancer]. Pol. Merkur. Lekarski 40:236 (2016), 89–93.
2. Campbell, J.D., Alexandrov, A., Kim, J., Wala, J., Berger, A.H., Pedamallu, C.S., Shukla, S.A., Guo, G., Brooks, A.N., Murray, B.A., Imielinski, M., Hu, X., Ling, S., Akbani, R., Rosenberg, M., Cibulskis, C., Ramachandran, A., Collisson, E.A., Kwiatkowski, D.J., Lawrence, M.S., Weinstein, J.N., Verhaak, R.G.W., Wu, C.J., Hammerman, P.S., Cherniack, A.D., Getz, G., N. Cancer Genome Atlas Research, Artyomov, M.N., Schreiber, R., Govindan, R., Meyerson, M., Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat. Genet. 48:6 (2016), 607–616.
3. Padda, S.K., Burt, B.M., Trakul, N., Wakelee, H.A., Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin. Oncol. 41:1 (2014), 40–56.
4. Wood, S.L., Pernemalm, M., Crosbie, P.A., Whetton, A.D., Molecular histology of lung cancer: from targets to treatments. Cancer Treat. Rev. 41:4 (2015), 361–375.
5. Jiang, T., Zhai, C., Su, C., Ren, S., Zhou, C., The diagnostic value of circulating cell free DNA quantification in non-small cell lung cancer: a systematic review with meta-analysis. Lung Cancer-j Iaslc 100 (2016), 63–70.
6. Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D., Bray, F., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136:5 (2015), E359–86.
7. Madhu, P., Manickam, I.N., Kanagasabapathy, H., Production and characterization of phenolic compounds by flash pyrolysis of palmyra palm, Energy Sources, Part A: recovery, Utilization. and Environmental Effects 38:15 (2016), 2161–2169.
8. Song, H., Bao, J., Wei, Y., Chen, Y., Mao, X., Li, J., Yang, Z., Xue, Y., Kaempferol inhibits gastric cancer tumor growth: an in vitro and in vivo study. Oncol. Rep. 33:2 (2015), 868–874.
9. Song, W., Dang, Q., Xu, D., Chen, Y., Zhu, G., Wu, K., Zeng, J., Long, Q., Wang, X., He, D., Li, L., Kaempferol induces cell cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38 signaling. Oncol. Rep. 31:3 (2014), 1350–1356.
10. Jo, E., Park, S.J., Choi, Y.S., Jeon, W.-K., Kim, B.-C., Kaempferol suppresses transforming growth Factor-β1–Induced epithelial-to-Mesenchymal transition and migration of A549 lung Cancer cells by inhibiting Akt1-Mediated phosphorylation of Smad3 at Threonine-179. Neoplasia 17:7 (2015), 525–537.
11. Kuo, W.T., Tsai, Y.C., Wu, H.C., Ho, Y.J., Chen, Y.S., Yao, C.H., Yao, C.H., Radiosensitization of non-small cell lung cancer by kaempferol. Oncol. Rep. 34:5 (2015), 2351–2356.
12. Lee, H.Y., Han, S.S., Song, S.Y., Serum microRNAs as potential biomarkers for lung cancer. Ann. Oncol., 27(suppl_6), 2016 1530P-1530P.
13. Gong, F.Y., Bai, T., Zhang, D.Y., Huang, C.L., Lv, J., Wang, J.L., Hu, X.D., Wang, J., Liu, W., Regulation mechanism of MicroRNAs in non-small cell lung Cancer. Curr. Pharm. Des., 2017.
14. Chae, D.K., Ban, E., Yoo, Y.S., Kim, E.E., Baik, J.H., Song, E.J., MIR-27a regulates the TGF-beta signaling pathway by targeting SMAD2 and SMAD4 in lung cancer. Mol. Carcinog. 56:8 (2017), 1992–1998.
15. Yang, Z., He, J., Gao, P., Niu, Y., Zhang, J., Wang, L., Liu, M., Wei, X., Liu, C., Zhang, C., Wang, W., Du, J., Li, H., Hu, W., Sun, G., miR-769-5p suppressed cell proliferation, migration and invasion by targeting TGFBR1 in non-small cell lung carcinoma. Oncotarget 8:69 (2017), 113558–113570.
16. Yu, J., Wang, R., Chen, J., Wu, J., Dang, Z., Zhang, Q., Li, B., miR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT Pathway. Med. Sci. Monit. 23 (2017), 71–77.
17. Fernandez, S., Risolino, M., Mandia, N., Talotta, F., Soini, Y., Incoronato, M., Condorelli, G., Banfi, S., Verde, P., miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene 34:25 (2015), 3240–3250.
18. Li, X., Gong, X., Chen, J., Zhang, J., Sun, J., Guo, M., miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2. Biochem. Bioph. Res. Co 460:3 (2015), 670–677.
19. Shi, Z., Li, Y., Qian, X., Hu, Y., Liu, J., Zhang, S., Zhang, J., MiR-340 inhibits triple-negative breast Cancer progression by reversing EZH2 mediated miRNAs dysregulated expressions. J. Cancer 8:15 (2017), 3037–3048.
20. Kim, K., Kim, S., Moh, S.H., Kang, H., Kaempferol inhibits vascular smooth muscle cell migration by modulating BMP-mediated miR-21 expression. Mol. Cell. Biochem. 407:1-2 (2015), 143–149.
21. Liu, T., Zhang, J., Chai, Z., Wang, G., Cui, N., Zhou, B., Ginkgo biloba extract EGb 761–induced upregulation of LincRNA-p21 inhibits colorectal cancer metastasis by associating with EZH2. Oncotarget 8:53 (2017), 91614–91627.
22. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:4 (2001), 402–408.
23. Dang, Q., Song, W., Xu, D., Ma, Y., Li, F., Zeng, J., Zhu, G., Wang, X., Chang, L.S., He, D., Li, L., Kaempferol suppresses bladder cancer tumor growth by inhibiting cell proliferation and inducing apoptosis. Mol Carcinogen 54:9 (2015), 831–840.
24. Zhang, Y., Chen, A.Y., Li, M., Chen, C., Yao, Q., Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic Cancer cells. J. Surg. Res. 148:1 (2008), 17–23.
25. Webster, A.F., Williams, A., Recio, L., Yauk, C.L., Bromodeoxyuridine (BrdU) treatment to measure hepatocellular proliferation does not mask furan-induced gene expression changes in mouse liver. Toxicology 323 (2014), 26–31.
26. Li, X., Hao, Z., Fan, R., Zou, X., Jin, H., Pan, Y., He, L., Du, R., Gao, L., Liu, D., Fan, D., CIAPIN1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating CyclinD1 and upregulating P27. Cancer Biol. Ther. 6:10 (2007), 1539–1545.
27. Ru, Y., Chen, X.-J., Zhao, Z.-W., Zhang, P.-F., Feng, S.-H., Gao, Q., Gao, S.-G., Feng, X.-S., CyclinD1 and p57(kip2) as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma. Oncotarget 8:43 (2017), 73860–73870.
28. Nguyen, T.T., Tran, E., Ong, C.K., Lee, S.K., Do, P.T., Huynh, T.T., Nguyen, T.H., Lee, J.J., Tan, Y., Ong, C.S., Huynh, H., Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J. Cell. Physiol. 197:1 (2003), 110–121.
29. Mizushima, N., PL-02Monitoring of autophagosome formation and maturation. Microscopy, 65(suppl_1), 2016 i3-i3.
30. Wu, H., Che, X., Zheng, Q., Wu, A., Pan, K., Shao, A., Wu, Q., Zhang, J., Hong, Y., Caspases: a molecular switch node in the crosstalk between autophagy and apoptosis. Int. J. Biol. Sci. 10:9 (2014), 1072–1083.
31. Chen, Y., Henson, E.S., Xiao, W., Huang, D., McMillan-Ward, E.M., Israels, S.J., Gibson, S.B., Tyrosine kinase receptor EGFR regulates the switch in cancer cells between cell survival and cell death induced by autophagy in hypoxia. Autophagy 12:6 (2016), 1029–1046.
32. Rubinstein, A.D., Kimchi, A., Life in the balance - a mechanistic view of the crosstalk between autophagy and apoptosis. J. Cell. Sci. 125:Pt 22 (2012), 5259–5268.
33. Mortensen, M., Soilleux, E.J., Djordjevic, G., Tripp, R., Lutteropp, M., Sadighi-Akha, E., Stranks, A.J., Glanville, J., Knight, S., Jacobsen, S.E., Kranc, K.R., Simon, A.K., The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J. Exp. Med. 208:3 (2011), 455–467.
34. Pattingre, S., Espert, L., Biard-Piechaczyk, M., Codogno, P., Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90:2 (2008), 313–323.
35. Pankiv, S., Clausen, T.H., Lamark, T., Brech, A., Bruun, J.A., Outzen, H., Overvatn, A., Bjorkoy, G., Johansen, T., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282:33 (2007), 24131–24145.
36. Kim, I.-R., Kim, S.-E., Baek, H.-S., Kim, B.-J., Kim, C.-H., Chung, I.-K., Park, B.-S., Shin, S.-H., The role of kaempferol-induced autophagy on differentiation and mineralization of osteoblastic MC3T3-E1 cells. BMC Complement. Altern. Med., 16(1), 2016, 333.
37. Huang, W.W., Tsai, S.C., Peng, S.F., Lin, M.W., Chiang, J.H., Chiu, Y.J., Fushiya, S., Tseng, M.T., Yang, J.S., Kaempferol induces autophagy through AMPK and AKT signaling molecules and causes G2/M arrest via downregulation of CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells. Int. J. Oncol. 42:6 (2013), 2069–2077.
38. Yamada, K.M., Araki, M., Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J. Cell. Sci. 114:Pt 13 (2001), 2375–2382.
39. Xie, F., Su, M., Qiu, W., Zhang, M., Guo, Z., Su, B., Liu, J., Li, X., Zhou, L., Kaempferol promotes apoptosis in human bladder cancer cells by inducing the tumor suppressor, PTEN. Int. J. Mol. Sci. 14:11 (2013), 21215–21226.
40. Martini, M., De Santis, M.C., Braccini, L., Gulluni, F., Hirsch, E., PI3K/AKT signaling pathway and cancer: an updated review. Ann. Med. 46:6 (2014), 372–383.
41. Kashafi, E., Moradzadeh, M., Mohamadkhani, A., Erfanian, S., Kaempferol increases apoptosis in human cervical cancer HeLa cells via PI3K/AKT and telomerase pathways. Biomed. Pharmacother. 89 (2017), 573–577.